Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

71 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Eligibility Carcinoma, Non-Small-Cell Lung NCT00087802

- 22/7/16 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00087802

Eligibility Carcinoma, Non-Small-Cell Lung NCT00071188

- 22/7/16 - 1 formulario, 2 itemgroups, 13 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00071188

Eligibility Carcinoma, Non-Small-Cell Lung NCT00061464

- 22/7/16 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.; ODM derived from: https://clinicaltrials.gov/show/NCT00061464

Eligibility Carcinoma, Non-Small Cell Lung NCT00190840

- 22/7/16 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00190840

Eligibility Carcinoma, Non-small Cell Lung NCT00093132

- 21/7/16 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00093132

Eligibility Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer NCT00590902

- 15/6/16 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00590902

Eligibility Stage IA Non-Small Cell Lung Carcinoma NCT02154399

- 5/6/16 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02154399

Eligibility Carcinoma, Non-Small-Cell Lung NCT02272413

- 6/5/16 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02272413

Eligibility Metastases of Central Nervous System NCT00831545

- 24/1/16 - 1 formulario, 2 itemgroups, 19 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064); ODM derived from: https://clinicaltrials.gov/show/NCT00831545

Eligibility Lung Cancer NCT00653250

- 19/1/16 - 1 formulario, 1 itemgroup, 16 items, 1 idioma
Itemgroup: Criteria
Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00653250

Eligibility Carcinoma, Non-small Cell Lung NCT00385996

- 21/12/15 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00385996

NCT00533949 A5: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Demographic Data Form - Version

- 3/7/15 - 1 formulario, 4 itemgroups, 40 items, 1 idioma
Itemgroups: Header, Patient demographics, Cigarette History, Family History
NCT00533949 A5: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Demographic Data Form - Version High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24F9E1D9-7462-4C05-E044-0003BA3F9857

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial